To assess the association of semaglutide with incident AUD, the study population included 598,803 patients with T2DM who had active medical encounters for T2DM during 12/20175/2021, were for the first time prescribed semaglutide or non-GLP1-1RA anti-diabetes medications (new-user design) during 12/20175/2021(index event), had no diagnosis of AUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
Kim JW, Byun MS, Yi D, et al
Drinking chia seed water in the morning can help with hydration, digestion, and energy levels
Information about seminal non-enzymatic antioxidants and male fertility potential is quite inadequate till date